Condition: B-cell Lymphoma · Acute Myeloid Leukemia · Myelodysplastic Syndrome · Sponsor: NovaOnco Therapeutics Co., Ltd.
Evaluation of the safety, tolerability, pharmacokinetics, and preliminary efficacy of XS-04 in patients with relapsed or refractory hematologic malignancies
This description comes directly from the study's public registry record.
Jun Zhu, MD · 88196922 · zhujun3346@163.com
Yuqin Song, MD · 88196922 · SongYQ_VIP@163.com
Always discuss trial participation with your own doctor first.
| Beijing Cancer Hospital | Beijing, China | Recruiting |
| Sun Yat-sen University Cancer Center | Guangdong, China | Not Yet Recruiting |
| Affiliated Hospital of Hebei University | Hebei, China | Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Hubei, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06820268